Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation – successful treatment with high-dose methylprednisolone and defibrotide

被引:0
|
作者
H. Sayer
U. Will
K. Schilling
T. Vogt
K. Wollina
K. Höffken
机构
[1] Klinik und Poliklinik für Innere Medizin II (Hämatologie,
[2] Onkologie,undefined
[3] Endokrinologie und Stoffwechselerkrankungen) der Friedrich-Schiller-Universität Jena,undefined
[4] Erlanger Allee 101,undefined
[5] 07740 Jena,undefined
[6] Germany,undefined
[7] Klinik und Poliklinik für Innere Medizin I (Gasteroenterologie,undefined
[8] Hepatologie und Infektiologie) der Friedrich-Schiller-Universität Jena,undefined
[9] Jena,undefined
[10] Germany,undefined
关键词
Allogeneic and autologous stem cell transplantation Veno-occlusive disease Sonography High-dose methylprednisolone Defibrotide;
D O I
暂无
中图分类号
学科分类号
摘要
Veno-occlusive disease (VOD) is a life-threatening complication following allogeneic or autologous stem cell transplantation. We report on a patient with a high grade B-cell lymphoma who presented 28 days after the second autologous stem cell transplantation with weight gain, ascites, hyperbilirubinemia, and liver venules occlusion as demonstrated by sonography. Starting with high-dose methylprednisolone treatment followed by defibrotide maintenance therapy the patient showed dramatic complete response of VOD, resulting in a normal sonography of the liver and normalization of laboratory values. The response of the occlusion of nearly all liver venules underlines the value of anti-inflammatory treatment combined with new thrombolytic medication such as defibrotide for the treatment of severe VOD.
引用
收藏
页码:148 / 152
页数:4
相关论文
共 50 条
  • [1] Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation -: successful treatment with high-dose methylprednisolone and defibrotide
    Sayer, HG
    Will, U
    Schilling, K
    Vogt, T
    Wollina, K
    Höffken, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (03) : 148 - 152
  • [2] Efficacy of Low Dose Defibrotide Prevention of Hepatic Veno-Occlusive Disease after Autologous Hematopoietic Stem Cell Transplantation
    Roh, Y. Y.
    Hahn, S. M.
    Choi, Y. H.
    Hong, J. P.
    Lyu, C. J.
    Han, J. W.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S510 - S510
  • [3] Efficient prophylaxis with defibrotide for hepatic veno-occlusive disease (VOD) after allogeneic stem cell transplantation (SCT).
    Chalandon, Y
    Roosnek, E
    Helg, C
    Newton, A
    Wacker, P
    Chapuis, B
    BLOOD, 2002, 100 (11) : 111A - 111A
  • [4] Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
    Corbacioglu, Selim
    Kernan, Nancy
    Lehmann, Leslie
    Brochstein, Joel
    Revta, Carolyn
    Grupp, Stephan
    Martin, Paul
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (03) : 291 - 302
  • [5] Defibrotide for the treatment of veno-occlusive disease after liver transplantation
    Mor, E
    Pappo, O
    Bar-Nathan, N
    Shaharabani, E
    Shapira, Z
    Tur-Kaspa, R
    Ben-Ari, Z
    TRANSPLANTATION, 2001, 72 (07) : 1237 - 1240
  • [6] High dose corticosteroids for treatment of hepatic veno-occlusive disease (VOD) complicating stem cell transplantation.
    Khoury, H
    Adkins, D
    Brown, R
    Goodnough, T
    DiPersio, J
    BLOOD, 1996, 88 (10) : 1646 - 1646
  • [7] Prophylactic defibrotide for the prevention of hepatic veno-occlusive disease (VOD) in hematopoietic stem cell transplantation (HSCT).
    Joshi, R
    Kerridge, I
    Grace, S
    Ethell, M
    Potter, M
    Prentice, HG
    BLOOD, 2002, 100 (11) : 413A - 414A
  • [8] Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan
    Sana Intidhar Labidi
    Catherine Sebban
    Hervé Ghesquières
    Emmanuele Virelizier Nicolas
    Pierre Biron
    International Journal of Hematology, 2008, 88 : 291 - 293
  • [9] Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan
    Labidi, Sana Intidhar
    Sebban, Catherine
    Ghesquieres, Herve
    Nicolas, Emmanuele Virelizier
    Biron, Pierre
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (03) : 291 - 293
  • [10] Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease
    Triplett, Brandon M.
    Kuttab, Hani I.
    Kang, Guolian
    Leung, Wing
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2148 - 2153